Genomic analysis of invasion-metastasis-related factors in pancreatic cancer cells

Egami H, Takiyama Y, Cano M, Houser WH and Pour PM: Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis. 10:861–869. 1989.

Egami H, Tomioka T, Tempero M, Kay D and Pour PM: Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters. Am J Pathol. 138:557–561. 1991.

Goggins M: Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol. 34:303–310. 2007.

Shi YH, Zhu SW, Mao XZ, et al: Transcriptome profiling, molecular biological and physiological studies reveal a major role for ethylene in cotton fiber cell elongation. Plant Cell. 18:651–664. 2006.

Tan X, Egami H, Kamohara H, et al: Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer. Int J Oncol. 24:65–73. 2004.

Duerr EM, Mizukami Y, Ng A, et al: Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr Relat Cancer. 15:243–256. 2008.

Jones S, Zhang X, Parsons DW, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analysis. Science. 321:1801–1806. 2008.

Capurso G, Lattimore S, Crnogorac-Jurcevic T, et al: Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr Relat Cancer. 13:41–58. 2006.

Pour PM, Egami H and Takiyama Y: Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implication. Gastroenterology. 100:529–536. 1991.

Kurizaki T, Egami H, Hirota M, et al: Characterization of cancer cell dissociation factor in a highly invasive pancreatic cancer cell line. Cancer. 75:1554–1561. 1995.

Morgia G, Falsaperla M, Malaponte G, et al: Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol Res. 33:44–50. 2004.

Iiizumi M, Liu W, Pai SK, Furuta E and Watabe K: Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta. 1786:87–104. 2008.

Klingbeil P and Marhaba R: CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Mol Cancer Res. 7:168–179. 2009.

Schuldt A: Nuclear pore assembly: locating the linchpin. Nat Cell Biol. 5:4972003.

Harel A, Orjalo AV, Vincent T, et al: Removal of a single pore subcomplex results in vertebrate nuclei devoid of nuclear pores. Mol Cell. 11:853–864. 2003.

Utepbergenov DI, Fanning AS and Anderson JM: Dimerization of the scaffolding protein ZO-1 through the second PDZ domain. J Biol Chem. 281:24671–24677. 2006.

Matter K and Balda MS: Functional analysis of tight junctions. Methods. 30:228–234. 2003.

Sato N, Fukushima N, Maitra A, et al: Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 63:3735–3742. 2003.

Martin TA, Watkins G, Mansel RE and Jiang WG: Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer. 40:2717–2725. 2004.

Harada T, Baril P, Gangeswaran R, et al: Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridization. Br J Cancer. 96:373–382. 2007.